Jun. 26, 2017 – Optel Group, a global provider of traceability systems for the pharmaceutical and medical device industries, has inaugurated its new manufacturing facility in Campinas, Brazil.
After a successful expansion at its Canadian headquarters, as well as recent sites in Ireland and India, Optel says it is “very pleased” to add Brazil to its list of worldwide locations.
This addition, according to the company, will allow it to better meet growing serialization demand and keep supporting the fight against counterfeit pharmaceuticals and medical devices throughout the world.
“Our new plant in Campinas, which is almost 1200 m2, will allow us to increase production, now and in the future, because the site also offers us the possibility of expanding our facilities by more than double later on,” said Louis Roy, Optel president.
“And thanks to the strong technical skills of the local workforce, our facilities in Campinas will be able to serve the entire Latin American region in terms of sales, production and system implementation,” added Amanda Neves, Campinas plant manager.